Marina Martinez-Lopez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: December 22, 2025

Bariatric Surgery Reverses ORG and Exhibits a Distinct Transcriptomic Profile Compared to Weight Loss Through a Low-Fat Diet.

Bariatric Surgery Reverses ORG and Exhibits a Distinct Transcriptomic Profile Compared to Weight Loss Through a Low-Fat Diet.

Journal: International journal of molecular sciences

Published: November 28, 2025

Real-World Impact of Finerenone on Albuminuria in Patients with Diabetes and CKD.

Real-World Impact of Finerenone on Albuminuria in Patients with Diabetes and CKD.

Journal: International journal of molecular sciences

Published: September 04, 2025

Fibrillary glomerulonephritis: clinicopathological characteristics and treatment in a spanish tertiary center.

Fibrillary glomerulonephritis: clinicopathological characteristics and treatment in a spanish tertiary center.

Journal: Nefrologia

Published: June 09, 2025

Obesity-Related Kidney Disease: A Growing Threat to Renal Health.

Obesity-Related Kidney Disease: A Growing Threat to Renal Health.

Journal: International journal of molecular sciences

Published: May 23, 2025

Promoting a turnaround in the management of renal disease in obese patients.

Promoting a turnaround in the management of renal disease in obese patients.

Journal: Nefrologia

Published: April 25, 2025

Experience with new anti-CD20 monoclonal antibodies for immune-mediated glomerulopathies in a tertiary hospital.

Experience with new anti-CD20 monoclonal antibodies for immune-mediated glomerulopathies in a tertiary hospital.

Journal: Nefrologia

Published: March 23, 2025

The Role of miRNAs as Early Biomarkers in Obesity-Related Glomerulopathy: Implications for Early Detection and Treatment.

The Role of miRNAs as Early Biomarkers in Obesity-Related Glomerulopathy: Implications for Early Detection and Treatment.

Journal: Biomedicines

Published: March 18, 2025

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial.

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial.

Journal: Nature medicine

Published: September 03, 2024

Integrated miRNA-mRNA Analysis Reveals Critical miRNAs and Targets in Diet-Induced Obesity-Related Glomerulopathy.

Integrated miRNA-mRNA Analysis Reveals Critical miRNAs and Targets in Diet-Induced Obesity-Related Glomerulopathy.

Journal: International journal of molecular sciences

Published: May 01, 2024

Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?

Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?

Journal: Clinical kidney journal

Published: December 20, 2023

Obesity Weight Loss Phenotypes in CKD: Measured GFR and Albumin-to-Creatinine Excretion Ratio Place for Stratification.

Obesity Weight Loss Phenotypes in CKD: Measured GFR and Albumin-to-Creatinine Excretion Ratio Place for Stratification.

Journal: Kidney international reports

Published: July 23, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026